[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 23, 1995

Calcium Channel Blockers and Myocardial InfarctionA Hypothesis Formulated but Not Yet Tested

Author Affiliations

From the Division of Preventive Medicine, Department of Medicine (Drs Buring, Glynn, and Hennekens), and Department of Ambulatory Care and Prevention (Drs Buring and Hennekens), Harvard Medical School, and Brigham and Women's Hospital (Drs Buring, Glynn, and Hennekens), Boston, Mass.

JAMA. 1995;274(8):654-655. doi:10.1001/jama.1995.03530080070044
Abstract

In this week's JAMA, Psaty and colleagues1 present findings from a case-control study that raise the possibility, but cannot evaluate definitively, whether calcium channel blockers prescribed for patients with hypertension increase risk of myocardial infarction. This retrospective study among enrollees of the Group Health Cooperative of Puget Sound compared those who had suffered a myocardial infarction (cases) with those who had not (controls), with respect to their prior use of various antihypertensive drug therapies. The authors reported that risk of myocardial infarction increased about 60% (risk ratio=1.6; 95% confidence interval [CI], 1.1 to 2.3) among hypertensive patients treated with a calcium channel blocker compared with those treated with diuretics alone, and this apparent adverse effect was even greater among those treated with high doses.

See also p 620.

Unfortunately, media reporting of the presentation of these findings at a recent scientific meeting triggered concern among users of these and

First Page Preview View Large
First page PDF preview
First page PDF preview
×